Clinical trials in Hodgkin lymphoma

The list below shows The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.

  • RADAR - testing brentuximab vedotin, combined with chemotherapy, in people with stage 1A or 2A Hodgkin lymphoma who haven’t had treatment before.
  • AZD7789 - testing AZD7789 in people with relapsed or refractory classical Hodgkin lymphoma.

With special thanks to the following:

Lymphoma actionCRUKBloodwiseNCRI

For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.

Last updated: October 2023